NCT04234997 - Suvorexant to Reduce Symptoms of Nicotine Use | Biotech Hunter

Enrollment

14

Participants

Timeline

Start Date

August 23, 2021

Primary Completion Date

August 22, 2024

Study Completion Date

August 22, 2024

Conditions

Smoking Cessation

Interventions

DRUG

Suvorexant 20 mg

Participants will be advised to take the medication at 10PM for 7 days.Participants will be instructed to stop smoking by 10 pm the day before, in order to ensure they meet the breath CO criterion (CO ≤ 4 ppm) indicating overnight abstinence.

DRUG

Suvorexant 0mg

Participants will be advised to take the medication at 10PM for 7 days.Participants will be instructed to stop smoking by 10 pm the day before, in order to ensure they meet the breath CO criterion (CO ≤ 4 ppm) indicating overnight abstinence.

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston